DAFNA Capital Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

DAFNA Capital Management’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-19,324	Closed	-$176K	–	97
2022 Q1	$176K	Hold	19,324	–	–	0.05%	92
2021 Q4	$415K	Hold	19,324	–	–	0.1%	84
2021 Q3	$632K	Hold	19,324	–	–	0.17%	75
2021 Q2	$806K	Buy	+19,324	New	+$990K	0.17%	74
2015 Q3	–	Sell	-2,864	Closed	-$555K	–	94
2015 Q2	$555K	Hold	2,864	–	–	0.47%	51
2015 Q1	$424K	Hold	2,864	–	–	0.33%	50
2014 Q4	$447K	Hold	2,864	–	–	0.35%	47
2014 Q3	$411K	Sell	2,864 -2,705	-49%	-$392K	0.41%	40
2014 Q2	$727K	Hold	5,569	–	–	0.69%	32
2014 Q1	$682K	Hold	5,569	–	–	0.59%	33
2013 Q4	$591K	Hold	5,569	–	–	0.61%	35
2013 Q3	$625K	Hold	5,569	–	–	0.68%	38
2013 Q2	$628K	Buy	+5,569	New	+$681K	0.92%	30

Other funds holding SRGA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DAFNA Capital Management's SRGA Position: Q2 2022 in Review

DAFNA Capital Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2022, closing a stake of 19,324 shares — an estimated $176K sold.

DAFNA Capital Management first reported a position in SRGA in Q2 2013 and held it in 13 quarters. The position peaked at $806K in Q2 2021. 40 funds tracked by Wall St. Rank hold SRGA as of Q2 2022.

DAFNA Capital Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
DAFNA Capital Management sold 19,324 Surgalign Holdings, Inc. Common Stock shares in Q2 2022, an estimated $176K.
DAFNA Capital Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 13 quarters.
DAFNA Capital Management's Surgalign Holdings, Inc. Common Stock position peaked at $806K in Q2 2021.
40 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2022.

Based on DAFNA Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.